The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index; 23 of the 43 sources its claims cite were checked for support.
Biological variation in serum thyroid, iron metabolism, and plasma bone metabolism biomarkers in patients with type 2 diabetes mellitus
Open accessAbstract
Objectives: Variability in biomarkers is crucial for clinical decision-making in individuals with type 2 diabetes mellitus (T2DM). The biological variation (BV) of biomarkers associated with thyroid function, iron metabolism, and bone metabolism may show population-specific differences. This study aims to evaluate the biological variation of sixteen biomarkers in T2DM patients and compare these with variations observed in a healthy population. Methods: Twenty-four T2DM patients, aged 43 to 67 and in stable condition, were enrolled. Blood samples were collected biweekly for three months. Analysis of variance models were used to assess the BV, including within-subject BV (CV I), between-subject BV (CV G), analytical variation, reference change value (RCV), index of individuality (II), the number of samples required for steady-state set points (NHSP), and analytical performance specifications for all biomarkers. Results: Females exhibited lower CV I estimates for thyroid-stimulating hormone, parathyroid hormone, and phosphate compared to males. No significant differences in CV I estimates were observed between T2DM patients and healthy individuals across the study. However, the CV G estimates for cortisol and iron were significantly lower in T2DM patients compared to the healthy individuals. Conclusions: BV data is critical for the precise interpretation of serial biomarker level changes in T2DM patients. It is deemed reasonable to use RCVs for four bone metabolism markers and five thyroid biomarkers, derived from a healthy population, as a reference for monitoring T2DM patients.
Overview
CoChat Summary
TL;DR
This study estimated biological variation (BV) for 16 thyroid, iron metabolism, and bone metabolism biomarkers in 24 patients with stable type 2 diabetes mellitus (T2DM) sampled biweekly for three months. Overall within-subject BV was similar to healthy populations, but between-subject BV for cortisol and iron was lower in T2DM, and the authors concluded that healthy-population reference change values (RCVs) are reasonable for four bone and five thyroid biomarkers in stable T2DM patients.
Key findings
- In 24 T2DM patients (11 men, 13 women; 136 results), female CVI estimates were lower than male estimates for TSH (15.2% vs 21.9%), PTH (15.2% vs 21.9%), and PHOS (5.6% vs 10.1%) based on non-overlapping 95% CIs.
- No significant differences in CVI estimates were observed between T2DM patients and healthy individuals across the study, but CVG estimates for cortisol and iron were significantly lower in T2DM than in the EFLM BV database: cortisol 18.8% vs 33.6%, and iron 9.7% vs 26.7%.
- Index of individuality (II) values were <0.6 for five thyroid hormones, INS, C-P, 25(OH)D, and TIBC, whereas II values were >1.4 for iron (1.98), TSAT (1.53), and Ca (1.43). Example RCVs were TSH −39.7%; +65.8% and iron −41.2%; +70.3%.
- The authors conclude it is reasonable to use RCVs for four bone metabolism markers and five thyroid biomarkers derived from a healthy population as a reference for monitoring stable T2DM patients.
Methods
- Prospective BV study enrolling 24 T2DM patients aged 43–69 years (inclusion criteria 18–70 years) on stable diabetes medication for at least 3 months, excluding insulin, vitamin D supplements, or thyroid-affecting medications; fasting venous blood was collected biweekly six times over three months, with 20 participants completing all six collections and four completing four collections (mean 5.7 samples per participant).
- Sixteen serum/plasma biomarkers were measured: thyroid markers (TSH, FT3, FT4, T3, T4), cortisol, insulin, C-peptide, intact PTH, 25(OH)D, calcium, phosphate, iron, UIBC, TSAT, and TIBC; assays used Roche Cobas e601 and Cobas 8000, with all samples measured in duplicate in a single run.
- Analysis used ANOVA or CV-ANOVA for CVA and CVI, nested ANOVA for CVG after outlier testing, Shapiro-Wilk testing with log-transformation for non-normal data, linear regression for steady state, Miller’s formula for 95% CIs, and non-overlapping 95% CIs to define significant differences; RCV, II, NHSP, and analytical performance specifications were calculated.
Limitations
- The paper states that the study mainly focused on patients over 50 years old, with only three patients between 40 and 50 years of age, highlighting a gap in BV assessment for younger patients; it also notes that hormonal analytes are influenced by rhythms and seasons and that more precise BV analysis is needed.
- The paper states that CVA was derived from repeated samples and that laboratories should estimate RCVs based on their specific conditions.
- Evident from the text: the sample was small (24 enrolled, only 20 completed all six collections), there was no concurrent healthy control group, and comparisons with healthy populations relied on the EFLM BV database or previously published studies; the abstract reports ages 43–67 while the results report 43–69.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
13 Valid · 3 Not valid · 15 Not checked · 21 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Previous studies have explored BV in conditions such as kidney transplantation, chronic liver disease, and heart failure (6, 9, 10), revealing that BV data from healthy individuals often differs from those in unhealthy populations.”
§ Biological variation in serum thyroid, iron metabolism, and plasma bone metabolism biomarkers in patients with type 2 diabetes mellitus > Introduction
What the sources say
- Disputedcites [6] Meijers, 2017, Variability of biomarkers in patients with chronic heart failure and healthy controls, Eur J Heart Fail sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says that biological variation was comparable in healthy subjects and patients with stable chronic heart failure, despite different biomarker levels. The Results (page unavailable) identify differences for four markers, but the paper’s overall finding is contrary to the claim that biological variation often differs between healthy and unhealthy populations. (LLM, conf=0.87)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [9] Trapé, 2003, Reference change value for alpha-fetoprotein and its application in early detection of hepatocellular carcinoma in patients with hepatic disease, Clin Chem sourceExperimental — accuracy not yet measured
The introduction says within-subject biological variation may differ in diseases that alter a constituent’s regulation and identifies chronic liver disease as an AFP example. The study compares patients with hepatic disease against patients with a nonhepatic condition, not healthy individuals, and does not establish that such differences occur often. (LLM, conf=0.82)
- Not checked — no full text of the sourcecites [10] Biosca, 2006, Biological variation at long-term renal post-transplantation, Clin Chim Acta source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
Every source the paper cites for this claim was checked and supports it.
In the paper
“T2DM can lead to a decrease in thyroid-stimulating hormone (TSH) levels and impair the transformation of thyroxine (T4) to triiodothyronine (T3) in the peripheral tissues (11).”
§ Biological variation in serum thyroid, iron metabolism, and plasma bone metabolism biomarkers in patients with type 2 diabetes mellitus > Introduction
What the sources say
- Supportedcites [11] Kalra, 2019, Thyroid dysfunction and type 2 diabetes mellitus: screening strategies and implications for management, Diabetes Ther source
The “Effects of Diabetes on Thyroid Disorders” section (page not specified) says diabetes alters TSH levels and that, in euthyroid patients with diabetes, the nocturnal TSH peak is absent or reduced. This supports the qualified claim that T2DM can lead to a decrease in TSH, though the section specifically describes the nocturnal peak. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“There are strong associations between diabetes mellitus and numerous concurrent health issues, such as osteoporosis, thyroid dysfunction, and abnormalities in iron metabolism (2–4).”
§ Biological variation in serum thyroid, iron metabolism, and plasma bone metabolism biomarkers in patients with type 2 diabetes mellitus > Introduction
What the sources say
- Supportedcites [2] Biondi, 2019, Thyroid dysfunction and diabetes mellitus: two closely associated disorders, Endocr Rev source
The section “Underlying Mechanisms of the Association Between TD and Type 2 DM” states that thyroid dysfunction is more common in patients with type 2 diabetes than in the general population. This supports the association attributed to the paper; the claim does not require support for the other health issues listed in the citing sentence. (LLM, conf=0.92)
- Could not verifycites [3] Khosla, 2021, Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus, Nat Rev Endocrinol sourceExperimental — accuracy not yet measured
The Abstract discusses increased fracture risk and skeletal fragility in type 2 diabetes, but does not address thyroid dysfunction. Searches for thyroid dysfunction, hypothyroidism and hyperthyroidism found no passage in our copy supporting the claimed association. (LLM, conf=0.75)
- Could not verifycites [4] Miao, 2023, Iron metabolism and ferroptosis in type 2 diabetes mellitus and complications: mechanisms and therapeutic opportunities, Cell Death Dis sourceExperimental — accuracy not yet measured
The Introduction and Conclusion discuss links between type 2 diabetes and iron metabolism, not thyroid dysfunction. Searches for thyroid dysfunction and thyroid-hormone disorders found no passage in our copy addressing an association with diabetes. (LLM, conf=0.76)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“T2DM can lead to a decrease in thyroid-stimulating hormone (TSH) levels and impair the transformation of thyroxine (T4) to triiodothyronine (T3) in the peripheral tissues (11).”
§ Biological variation in serum thyroid, iron metabolism, and plasma bone metabolism biomarkers in patients with type 2 diabetes mellitus > Introduction
What the sources say
- Supportedcites [11] Kalra, 2019, Thyroid dysfunction and type 2 diabetes mellitus: screening strategies and implications for management, Diabetes Ther source
The Abstract explicitly states that T2DM impairs peripheral conversion of T4 to T3 and reduces TSH levels. The “Effects of Diabetes on Thyroid Disorders” section also describes impaired peripheral T4-to-T3 conversion. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Meanwhile, patients with T2DM exhibited comparable CVI, CVG, and RCV estimates to those from another study focusing on the elderly population (31).”
§ Biological variation in serum thyroid, iron metabolism, and plasma bone metabolism biomarkers in patients with type 2 diabetes mellitus > Discussion
What the sources say
- Supportedcites [31] Riis, 2023, Biological variation in thyroid function tests in older adults and clinical implications, Clin Endocrinol (Oxf) source
Table 2 (Discussion) reports intraindividual and interindividual coefficients of variation and reference change values for thyroid tests in older adults. The source supplies the elderly-population estimates used as the comparator; the comparison with patients with T2DM is the citing authors’ own finding. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
25 more claims · 3 with their cited sources checked
Create a free account to see all 52 claims and every source verdict.
- It may state two separate claims as one. 9
- Probably not a substantial claim. 17
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Biological variation in serum thyroid, iron metabolism, and plasma bone metabolism biomarkers in patients with type 2 diabetes mellitus > Abstract > Methods
“Twenty-four T2DM patients, aged 43 to 67 and in stable condition, were enrolled.”
§ Biological variation in serum thyroid, iron metabolism, and plasma bone metabolism biomarkers in patients with type 2 diabetes mellitus > Results
“Twenty-four patients diagnosed with T2DM (11 men and 13 women), aged 43–69 years, were included in this study.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Biological variation in serum thyroid, iron metabolism, and plasma bone metabolism biomarkers in patients with type 2 diabetes mellitus > Results
“| 25 (OH)D,mol/l | All participants |”
§ Biological variation in serum thyroid, iron metabolism, and plasma bone metabolism biomarkers in patients with type 2 diabetes mellitus > Results
“| 25(OH)D, nmol/l | -18.4; 22.6 |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Biological variation in serum thyroid, iron metabolism, and plasma bone metabolism biomarkers in patients with type 2 diabetes mellitus > Results
“According to the 95% CI, CVI estimates for TSH, PTH, and PHOS calculated for females were lower than those derived for males.”
§ Biological variation in serum thyroid, iron metabolism, and plasma bone metabolism biomarkers in patients with type 2 diabetes mellitus > Materials and methods > Data analysis
“Differences in mean values and BV estimates between subgroups were considered significant if the 95% CI did not overlap.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Biological variation in serum thyroid, iron metabolism, and plasma bone metabolism biomarkers in patients with type 2 diabetes mellitus > Results
“| FPG, mmol/l | 6.52 (2.67) | 4.98 (1.05) | 5.11 (0.91) | 0.39 |”
§ Biological variation in serum thyroid, iron metabolism, and plasma bone metabolism biomarkers in patients with type 2 diabetes mellitus > Results
“| Number of participants | 24 | 11 | 13 | – |”
Citations
Cites
The burden and risks of emerging complications of diabetes mellitus
Tomic, D., Shaw, J. E., & Magliano, D. J. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00690-7 · Cited by 1,163
Generation and Application of Data on Biological Variation in Clinical Chemistry
Fraser, G. G., & Harris, E. K. (1989) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408368909106595 · Cited by 870 · cited 1×
“Therefore, it is important to accurately interpret variations in these biomarker results, which are in fl uenced by biological variation (BV) (5, 6).”
Dixon, W. J. (1953) · Biometrics · doi:10.2307/3001634 · Cited by 868
Mechanisms controlling cellular and systemic iron homeostasis
Galy, B., Conrad, M., & Muckenthaler, M. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00648-1 · Cited by 785 · cited 1×
“Iron overload or de fi ciency can lead to metabolic disorders (41), making it crucial to evaluate BV values for iron metabolic markers in such conditions.”
Thyroid dysfunction and diabetes mellitus: two closely associated disorders
Biondi, B., Kahaly, G. J., & Robertson, R. P. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00163 · Cited by 598 · cited 1×
“There are strong associations between diabetes mellitus and numerous concurrent health issues, such as osteoporosis, thyroid dysfunction, and abnormalities in iron metabolism (2 – 4).”
Circadian clock control of endocrine factors
Gamble, K. L., Berry, R., Frank, S. J., & Young, M. E. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.78 · Cited by 521
Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment
Tebben, P. J., Singh, R. J., & Kumar, R. (2016) · Endocrine Reviews · doi:10.1210/er.2016-1070 · Cited by 442
Krall, E. A., Sahyoun, N., Tannenbaum, S., Dallal, G. E., & Dawson-Hughes, B. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912283212602 · Cited by 345
Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus
Khosla, S., Samakkarnthai, P., Monroe, D. G., & Farr, J. N. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00555-5 · Cited by 260
Aarsand, A. K., Røraas, T., Fernandez-Calle, P., Ricos, C., Díaz-Garzón, J., Jonker, N., Perich, C., González-Lao, E., Carobene, A., Minchinela, J., et al. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2017.281808 · Cited by 233
Miao, R., Fang, X., Zhang, Y., Wei, J., Zhang, Y., & Tian, J. (2023) · Cell Death & Disease · doi:10.1038/s41419-023-05708-0 · Cited by 192
Thyroid hormones in diabetes, cancer, and aging
Gauthier, B. R., Sola‐García, A., Cáliz‐Molina, M. Á., Lorenzo, P. I., Cobo‐Vuilleumier, N., Capilla‐González, V., & Martín‐Montalvo, A. (2020) · Aging Cell · doi:10.1111/acel.13260 · Cited by 168 · cited 2×
“Common measurands of bone metabolism include calcium (Ca), phosphate (PHOS) and parathyroid hormone (PTH), and 25-hydroxyvitamin D [25(OH)D].”
Iron and the pathophysiology of diabetes
Harrison, A. V., Lorenzo, F. R., & McClain, D. A. (2023) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022522-102832 · Cited by 161 · cited 1×
“Moreover, high iron is a risk factor for T2DM (16), and biomarkers are used to assess iron homeostasis.”
Variability of biomarkers in patients with chronic heart failure and healthy controls
Meijers, W. C., van der Velde, A. R., Muller Kobold, A. C., Dijck-Brouwer, J., Wu, A. H., Jaffe, A., & de Boer, R. A. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.669 · Cited by 146
Røraas, T., Petersen, P. H., & Sandberg, S. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2012.187781 · Cited by 134
Røraas, T., Støve, B., Petersen, P. H., & Sandberg, S. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2015.252296 · Cited by 129
Kalra, S., Aggarwal, S., & Khandelwal, D. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-00700-4 · Cited by 128
The impact of type 2 diabetes on bone metabolism
Sanches, C. P., Vianna, A. G. D., & Barreto, F. D. C. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0278-1 · Cited by 115 · cited 1×
“Similarly, patients with T2DM frequently experience disturbances in bone and mineral metabolism (15).”
Asymptotic test statistics for coefficients of variation
Miller, G. E. (1991) · Communication in Statistics- Theory and Methods · doi:10.1080/03610929108830707 · Cited by 113
Variation in thyroid function tests in patients with stable untreated subclinical hypothyroidism
Karmisholt, J., Andersen, S., & Laurberg, P. (2008) · Thyroid · doi:10.1089/thy.2007.0241 · Cited by 97
Bottani, M., Aarsand, A. K., Banfi, G., Locatelli, M., Coşkun, A., Díaz-Garzón, J., Fernandez-Calle, P., Sandberg, S., Ceriotti, F., & Carobene, A. (2022) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-1885 · Cited by 46 · cited 1×
“In this study, the CV I and CV G estimates for TSH, FT3, and FT4 in patients with T2DM are similar to those reported in the European Biological Variation Study, which is also a mid-term study (30).”
Van Wyck, D. B., Alcorn, H., & Gupta, R. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.05.009 · Cited by 38
Thyagarajan, B., Howard, A. G., Durazo-Arvizu, R., Eckfeldt, J. H., Gellman, M. D., Kim, R. S., Liu, K., Mendez, A. J., Penedo, F. J., Talavera, G. A., et al. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.10.019 · Cited by 37
Current and emerging concepts in biological and analytical variation applied in clinical practice
Flatland, B., Baral, R. M., & Freeman, K. P. (2020) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15929 · Cited by 37
Ceriotti, F., Marco, J. D.-G., Fernández–Calle, P., Maregnani, A., Aarsand, A. K., Coşkun, A., Jonker, N., Sandberg, S., & Carobene, A. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2019-1182 · Cited by 36
Fernández-Calle, P., Díaz-Garzón, J., Bartlett, W., Sandberg, S., Braga, F., Beatriz, B., Carobene, A., Coskun, A., Gonzalez-Lao, E., Marques, F., et al. (2022) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2021-0904 · Cited by 31
Trapé, J., Botargues, J. M., Porta, F., Ricós, C., Badal, J. M., Salinas, R., Sala, M., & Roca, A. (2003) · Clinical Chemistry · doi:10.1373/49.7.1209 · Cited by 30
Analytical Performance Specifications for 25-Hydroxyvitamin D Examinations
Cavalier, E., Fraser, C., Bhattoa, H., Heijboer, A., Makris, K., Ulmer, C., Vesper, H., Vasikaran, S., Lukas, P., Delanaye, P., et al. (2021) · Nutrients · doi:10.3390/nu13020431 · Cited by 23
The use of reference change values in clinical laboratories
Bugdayci, G., Oguzman, H., Arattan, H., & Sasmaz, G. (2015) · Clinical Laboratory · doi:10.7754/clin.lab.2014.140906 · Cited by 21
Browning, M. C., Bennet, W. M., Kirkaldy, A. J., & Jung, R. T. (1988) · Clinical Chemistry · doi:10.1093/clinchem/34.4.696 · Cited by 17
Karmisholt, J., Andersen, S., & Laurberg, P. (2010) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365511003782778 · Cited by 14
Carobene, A., Guerra, E., Marqués-García, F., Boned, B., Locatelli, M., Coşkun, A., Díaz-Garzón, J., Fernandez-Calle, P., Sandberg, S., & Aarsand, A. K. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.06.038 · Cited by 13
Carobene, A., Lao, E. G., Simon, M., Locatelli, M., Coşkun, A., Díaz-Garzón, J., Fernandez-Calle, P., Sandberg, S., & Aarsand, A. K. (2022) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-1490 · Cited by 12
Corte, Z., & Venta, R. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.03.26 · Cited by 10
Biological variation at long-term renal post-transplantation
Biosca, C., Ricós, C., Lauzurica, R., & Petersen, P. H. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.12.018 · Cited by 9
Intraindividual variability of thyroid function tests in a pediatric population
Oladipo, O., Nenninger, D. A., Parvin, C. A., & Dietzen, D. J. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.03.030 · Cited by 7
Intra-individual variation of serum thyroxin and triiodothyronine in pregnancy.
Hölzel, W. G., & Deschner, W. (1988) · Clinical Chemistry · doi:10.1093/clinchem/34.10.2063 · Cited by 7 · cited 1×
“To date, BV studies on thyroid hormones have predominantly focused on healthy populations, with only a few examining patients with hypothyroidism or pregnant women (26, 27).”
Biological Variation of Thyroid Function Biomarkers over 24 hours
Zhang, Y., He, D.-H., Jiang, S.-N., Wang, H.-L., Xu, X.-H., & Kong, L.-R. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.11.007 · Cited by 5
Biological variation in thyroid function tests in older adults and clinical implications
Riis, J., Westergaard, L., Karmisholt, J., Andersen, S. L., & Andersen, S. (2023) · Clinical Endocrinology · doi:10.1111/cen.14973 · Cited by 5
Young, D. S. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.2.395a · Cited by 3
On the importance of sampling interval in studies of biological variation in thyroid function
Andersen, S., Riis, J., Karmisholt, J., & Andersen, S. L. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2022-1130 · Cited by 2 · cited 1×
“Moreover, the sampling interval must be considered when studying BV in thyroid hormone (28).”
Dittadi, R., Gelisio, P., Rossi, L., Frigato, F., & Gion, M. (2008) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2008.285 · Cited by 1
Metadata
- Authors
- Wang, X., Zhang, M., Liu, Z., Li, C., Li, Y., Huang, H., He, H., & Yu, X.
- Affiliations
- Sichuan University (CN)
- University of Electronic Science and Technology of China (CN)
- Corresponding author
- He, He
- Yu, Xijie
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2025-05-20
- Volume
- 16
- Pages
- 1506664-1506664
- ISSN
- 1664-2392 (ISSN-L)
- PMC
- PMC12129759
- OpenAlex
- W4410523281
- Cited by
- 0
- References
- 43
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Endocrinology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Sichuan University
- West China Hospital, Sichuan University
- Topics
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Keywords
- biological variation, type 2 diabetes, thyroid function biomarkers, iron metabolism, bone turnover markers, reference change value, thyroid-stimulating hormone, parathyroid hormone, phosphate, cortisol, sex differences, within-person variability, between-subject variability
- MeSH terms
- Adult, Aged, Bone and Bones, Diabetes Mellitus, Type 2, Female, Humans, Iron, Male, Middle Aged, Thyroid Gland, Biomarkers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.